2020
DOI: 10.4081/aiua.2020.3.200
|View full text |Cite
|
Sign up to set email alerts
|

Gelatin sponge (Spongostan®) and N-butyl-2-cyanoacrylate: Utility on percutaneous treatment of persistent urinary leakage after partial nephrectomy. Case report and review of the literature

Abstract: Introduction: Percutaneous treatment of persistent urinary fistula after partial nephrectomy using N-butyl-2-cyanoacrylate and gelatin sponge (Spongostan®) is an effective and relatively non-invasive procedure that should be considered when a conservative approach fails. Three successful cases of percutaneous embolization by using N-butyl-2-cyanoacrylate have been reported in the literature. To our knowledge, the use of Spongostan for the treatment of urinary fistula after partial nephrectomy has not been prev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Taking advantage of this knowledge, we very recently identified the optimal nano- and microtopography guiding intramembranous ossification-driven bone regeneration. In particular, we observed micropores of 60.66 ± 24.48 μm diameter and nanopores of 32.97 ± 1.41 nm size in the clinically approved collagen sponge Spongostan™ [ 14 ], which is commonly used as a haemostatic collagen sponge in a broad range of clinical settings [ 15 , 16 , 17 ]. A specific indication for the use of Spongostan as a haemostatic agent is for bleeding in patients with von Willebrand disease (vWD).…”
Section: Introductionmentioning
confidence: 99%
“…Taking advantage of this knowledge, we very recently identified the optimal nano- and microtopography guiding intramembranous ossification-driven bone regeneration. In particular, we observed micropores of 60.66 ± 24.48 μm diameter and nanopores of 32.97 ± 1.41 nm size in the clinically approved collagen sponge Spongostan™ [ 14 ], which is commonly used as a haemostatic collagen sponge in a broad range of clinical settings [ 15 , 16 , 17 ]. A specific indication for the use of Spongostan as a haemostatic agent is for bleeding in patients with von Willebrand disease (vWD).…”
Section: Introductionmentioning
confidence: 99%